1-7 of 7
Mario Luca Morieri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes

Alberto Maran, Mario Luca Morieri, Daniele Falaguasta, Angelo Avogaro, Gian Paolo Fadini
Journal: Diabetes Care
Diabetes Care 2022;45(10):2439–2444
https://doi.org/10.2337/dc22-0980
Published: 15 August 2022
View article titled, The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes
Open the PDF for The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes in another window
Journal Articles

Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies

Hetal S. Shah, Lorena Ortega Moreno, Mario Luca Morieri, Yaling Tang, Christine Mendonca, Jenny Marie Jobe, Jonathan B. Thacker, Joanna Mitri, Stefano Monti, Monika A. Niewczas, Subramaniam Pennathur, Alessandro Doria
Journal: Diabetes Care
Diabetes Care 2022;45(8):1882–1892
https://doi.org/10.2337/dc21-1789
Published: 26 July 2022
View article titled, Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies
Open the PDF for Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies in another window
Journal Articles

Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope?

Mario Luca Morieri
Journal: Diabetes Care
Diabetes Care 2022;45(7):1500–1502
https://doi.org/10.2337/dci22-0012
Published: 06 July 2022
View article titled, Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope?
Open the PDF for Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope? in another window
Journal Articles

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy

Benedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini
Journal: Diabetes Care
Diabetes Care 2021;44(1):e18–e21
https://doi.org/10.2337/dc20-1872
Published: 30 October 2020
View article titled, The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy
Open the PDF for The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy in another window
Journal Articles

Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial

Mario Luca Morieri, He Gao, Marie Pigeyre, Hetal S. Shah, Jennifer Sjaarda, Christine Mendonca, Timothy Hastings, Patinut Buranasupkajorn, Alison A. Motsinger-Reif, Daniel M. Rotroff, Ronald J. Sigal, Santica M. Marcovina, Peter Kraft, John B. Buse, Michael J. Wagner, Hertzel C. Gerstein, Josyf C. Mychaleckyj, Guillaume Parè, Alessandro Doria
Journal: Diabetes Care
Diabetes Care 2018;41(11):2404–2413
https://doi.org/10.2337/dc18-0709
Published: 27 September 2018
View article titled, Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial
Open the PDF for Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD

Hetal S. Shah, Mario Luca Morieri, Santica M. Marcovina, Ronald J. Sigal, Hertzel C. Gerstein, Michael J. Wagner, Alison A. Motsinger-Reif, John B. Buse, Peter Kraft, Josyf C. Mychaleckyj, Alessandro Doria
Journal: Diabetes Care
Diabetes Care 2018;41(2):348–355
https://doi.org/10.2337/dc17-1638
Published: 28 November 2017
View article titled, Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD
Open the PDF for Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD in another window
Includes: Supplementary data
Journal Articles

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

Hetal S. Shah, He Gao, Mario Luca Morieri, Jan Skupien, Skylar Marvel, Guillaume Paré, Gaia C. Mannino, Patinut Buranasupkajorn, Christine Mendonca, Timothy Hastings, Santica M. Marcovina, Ronald J. Sigal, Hertzel C. Gerstein, Michael J. Wagner, Alison A. Motsinger-Reif, John B. Buse, Peter Kraft, Josyf C. Mychaleckyj, Alessandro Doria
Journal: Diabetes Care
Diabetes Care 2016;39(11):1915–1924
https://doi.org/10.2337/dc16-0285
Published: 15 August 2016
View article titled, Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial
Open the PDF for Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial in another window
Includes: Supplementary data